Shares of TransCanada Corporation (NYSE:TRP) opened at $48.63, and ended -1.11% lower at $48.05. Nearly 0.93 million shares were traded by the close, higher than its average daily volume of 0.8 million shares.TransCanada Corporation (TRP) Analyst Opinion
TransCanada Corporation has a consensus outperform rating from 10 Wall Street analysts, and the number of shares currently sold short amount to at least 0.52% of shares outstanding. The stock sank -4.05% last month and is up 6.42 this year. Wall Street is only getting more bullish on the stock, with 7 of analysts who cover TRP having a buy-equivalent rating. Analysts have placed a $56.81 price target on TransCanada Corporation, suggesting a 18.23% gain from recent close. It’s currently trading about -7.33% below its 52-week high.TransCanada Corporation Earnings Surprise
TransCanada Corporation (TRP) surprised the stock market in its last reported earnings when it earned $0.76 a piece versus the consensus-estimated $0.68. Its revenue totaled $3.14 billion down -7.42% from the previous quarter.TransCanada Corporation (NYSE:TRP) Intraday View
This stock (TRP) is ahead of its 52-week low with 12.56%. Its last month’s stock price volatility remained 1.65% which for the week stands at 1.14%. The share price has moved backward from its 20 days moving average, trading at a distance of -3.07% and stays -4.05% away from its 50 days moving average. Over the last five days, shares have faced -4.91% losses and now is down -0.15% since hitting its 200-day moving average of $48.79. TransCanada Corporation (TRP) has made its way to a 12-month gain of 3.85%.
Turning to CytomX Therapeutics, Inc. (NASDAQ:CTMX), its shares were trading at $20.09 a gain of $0.05, on the trading floor. The stock, after opening at $20.34, touched a high of $20.61 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.7. CytomX Therapeutics, Inc. has 3 buy ratings, 1 holds and 0 sells even after the stock tumbled -18.57% from its high of $24.67 to a $738.11 million market value through last close.CytomX Therapeutics, Inc. (NASDAQ:CTMX) Intraday Trading
The counter witnessed a trading volume of 0.3 million shares versus an average volume of 0.32 million shares during last trading session. Its last month’s stock price volatility remained 3.43% which for the week approaches 4.66%. The lowest price the stock reached in the last trading day was $19.93 and compares with the $9.85 52-week low. The stock recovered 103.96% since its low point and has performed 82.8% year-to-date.